| 摘要 |
FIELD: medicine. ^ SUBSTANCE: method is based on immune response antigen-antibody combined with detection of specific antibodies IgG and/or IgE concentration by means of immune-enzyme analysis. Concentration of IgG and/or IgE specific with respect to allergens contained in various SBFS is detected by means of test-system including antigen pattern - gross protein-peptide fractions extracted from various SBFS, notably: therapeutic (high-hydrolysed) preparations, therapeutic-preventive preparations (partially-hydrolysed breast milk substitute and phytalbumin-based), native protein-based breast milk substitute preparations and breast milk. And in case of increased concentration of specific IgG more 10 mcg/ml and/or detected specific IgE concentrated more 5 ng/ml, somato-allergic reaction (SAR) development risk is diagnosed with respect to specific SBFS. ^ EFFECT: increased accuracy and reliability of diagnostics somato-allergic reaction (SAR) development risk. ^ 2 cl, 4 ex, 6 dwg |
